<DOC>
	<DOCNO>NCT00535405</DOCNO>
	<brief_summary>A multicenter study evaluate safety efficacy ezetimibe/simvastatin versus atorvastatin elderly patient high cholesterol high moderately high risk coronary heart disease .</brief_summary>
	<brief_title>A Study Assess Cholesterol Lowering Effect Ezetimibe/Simvastatin Combination Tablet Compared Another Cholesterol Lowering Drug Elderly Patients With High Cholesterol High Moderately High Risk Coronary Heart Disease ( 0653A-128 )</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Ezetimibe , Simvastatin Drug Combination</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Patient cholesterol level 130 mg/dL great Patient willing maintain cholesterol lower diet long study Patient moderate high risk high risk coronary heart disease per National Cholesterol Education Program Adult Treatment Panel III ( NCEP ATPIII ) guideline Patient weigh less 100 lbs Patient allergy ezetimibe , simvastatin atorvastatin</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>High Cholesterol</keyword>
</DOC>